ReviewAnnals of hematology2024

Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.

Ivan Krecak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.